# Comparative Effects of Cellulose- and Gelatin-Based Hemostatic Biomaterials on the Early Stage of Wound Healing—An In Vivo Study

**Authors:** Helena Hae In Ströthoff, Polina Shabes, Katharina Henrika Beckamp, Markus Udo Wagenhäuser, Wiebke Ibing, Julian-Dario Rembe, Hubert Schelzig, Waseem Garabet

PMC · DOI: 10.3390/jfb17020064 · 2026-01-27

## TL;DR

This study compares how cellulose- and gelatin-based hemostatic materials affect early wound healing in mice, finding that gelatin-based materials support better healing without causing excessive inflammation.

## Contribution

The study provides new in vivo evidence on how different hemostatic biomaterials influence early wound healing processes.

## Key findings

- Gelatin-based materials showed enhanced extracellular matrix deposition and increased macrophage presence.
- GELA group exhibited elevated Ki-67 expression, indicating enhanced cellular proliferation.
- None of the biomaterials impaired wound healing or caused excessive inflammation.

## Abstract

Hemostatic biomaterials are widely used in surgical and trauma settings, yet their influence on early wound healing remains incompletely understood. This in vivo study investigated the effects of cellulose- and gelatin-based hemostatic biomaterials on early wound healing using a murine skin wound model. Oxidized non-regenerated cellulose (ONRC), oxidized regenerated cellulose (ORC), and a porcine gelatin-based matrix (GELA) were left in situ following standardized subcutaneous implantation and compared with sham-treated controls. Tissue responses were analyzed at postoperative days 3 and 7 using histology, immunohistochemistry, and quantitative real-time polymerase chain reaction (qPCR). Cellulose-based materials persisted as eosinophilic remnants, whereas fibrous matrix structures and enhanced extracellular matrix deposition were observed in the GELA group. Immunohistochemical analysis revealed increased cluster of differentiation 68 (CD68)–positive macrophage presence in the ORC group at day 3 and in the GELA group at day 7, indicating biomaterial-dependent modulation of macrophage involvement during early wound healing. Expression of Kiel 67 (Ki-67), a marker of cellular proliferation, was significantly elevated in the epidermis of the GELA group at day 7, suggesting enhanced proliferative activity during the reparative phase. In contrast, no significant differences were detected in the expression of interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), or cluster of differentiation 14 (CD14) between groups. Overall, none of the investigated biomaterials impaired early wound healing, while the gelatin-based material demonstrated features consistent with enhanced reparative cellular responses without excessive inflammation.

## Linked entities

- **Genes:** CD68 (CD68 molecule) [NCBI Gene 968], Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345], IL6 (interleukin 6) [NCBI Gene 3569], TNF (tumor necrosis factor) [NCBI Gene 7124], CD14 (CD14 molecule) [NCBI Gene 929]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CD14 (CD14 molecule) [NCBI Gene 929], IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Cd68 (Cd68 molecule) [NCBI Gene 287435], Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, Il1 (interleukin 1 complex) [NCBI Gene 111343] {aka Il-1}, Fgf2 (fibroblast growth factor 2) [NCBI Gene 14173] {aka Fgf-2, Fgf2a, Fgfb, bFGF}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Cd14 (CD14 antigen) [NCBI Gene 12475], Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}
- **Diseases:** ulcers (MESH:D014456), weight loss (MESH:D015431), wound infection (MESH:D014946), myocardial infarction (MESH:D009203), hypertrophic scar (MESH:D017439), tissue injury (MESH:D017695), necrosis (MESH:D009336), dislocation (MESH:D004204), hypertrophic (MESH:D002312), proinflammatory cytokines (MESH:D000080424), cancer (MESH:D009369), diabetic (MESH:D003920), ORC (MESH:D028361), dysplasia (MESH:D015792), fibrosis (MESH:D005355), platelet aggregation (MESH:D001791), Inflammatory (MESH:D007249), injury to (MESH:D014947), burn injury (MESH:D002056), respiratory distress (MESH:D012128), spinal cord injury (MESH:D013119), ONRC (MESH:D000073296), paralysis (MESH:D010243), bleeding (MESH:D006470)
- **Chemicals:** Octeniderm (MESH:C034213), dinitrogen tetroxide (MESH:C015167), metamizole (MESH:D004177), hematoxylin (MESH:D006416), GELITA  TUFT-IT (-), ROS (MESH:D017382), DAPI (MESH:C007293), Cellulose (MESH:D002482), eosin (MESH:D004801), Prolene (MESH:D011126), paraformaldehyde (MESH:C003043), LPS (MESH:D008070), SYBR Green (MESH:C098022), polyuronic acid (MESH:C018402), nitrogen (MESH:D009584), xylazine (MESH:D014991), polysaccharide (MESH:D011134), alginate (MESH:D000464), chitosan (MESH:D048271), ethanol (MESH:D000431), isoflurane (MESH:D007530), water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942278/full.md

---
Source: https://tomesphere.com/paper/PMC12942278